Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge
Lung Cancer International · 2016
DOI: 10.1155/2016/6787648 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lung Cancer International, 2016. Verfasst von Daniel Satgé und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oncodéfi, Parc Euromédecine, 209 avenue des Apothicaires, Parc Euromédecine, 34 090 Montpellier, France; Team Biostatistics Epidemiology Public Healt…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation Jérôme Lejeune.
Abstract (Originalsprache)
As the life expectancy of people with intellectual disability (ID) has progressed, they have become similarly at risk of cancer as individuals of the general population. Epidemiological studies indicate a reduced incidence and mortality from lung cancer in the total population of persons with ID. However, the pattern is heterogeneous and the risk is strongly correlated with the impairment level; persons with mild intellectual impairment have higher cancer risk, and this subgroup also has the highest tobacco consumption (the major risk factor for lung cancer) compared to individuals with more severe impairment. Clinical presentation of lung cancer in persons with ID is often atypical, with symptoms frequently hidden by the mental state and communication impairments. Treatment can be impeded by incomplete understanding and lack of cooperation on the part of the patient; nevertheless, general principles for treating lung cancer must be applied to persons with ID. Early diagnosis and implementation of an adapted treatment plan may result in lung cancer outcomes similar to those of individuals in the general population. Physicians facing the difficult task of treating lung cancer in persons with ID are called to carry out their mission of care in a responsible, free, and creative way.
Autor:innen und Institutionen
- Oncodéfi, Parc Euromédecine, 209 avenue des Apothicaires, Parc Euromédecine, 34 090 Montpellier, France; Team Biostatistics Epidemiology Public Health, EA 2415, University Institute for Clinical Research, 34 093 Montpel…
- Medical Oncology Department, Hôpital Henri Mondor, AP-HP, 51 avenue du Maréchal de Lattre de Tassigny, 94 010 Créteil, France; Pierre et Marie Curie University, Paris, France.
- Oncodéfi, Parc Euromédecine, 209 avenue des Apothicaires, Parc Euromédecine, 34 090 Montpellier, France; Radiotherapy Service, Institut de Cancérologie Val d'Aurelle, Parc Euromédecine, 208 avenue des Apothicaires, 34 2…
- Department of Fundamental Health Sciences, Health Sciences University of Hokkaido, Tobetsu, Hokkaido 061-0293, Japan.
- Descartes University, Paris, France; Unit of Thoracic Oncology Service, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75 014 Paris, France.
ORCID-Profile: Daniel Satgé
Förderung
- Fondation Jérôme Lejeune
Zitieren
APA
Satgé, D., Kempf, E., Dubois, J. B., Nishi, M., & Trédaniel, J. (2016). Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge. Lung Cancer International. https://doi.org/10.1155/2016/6787648
Vancouver
Satgé D, Kempf E, Dubois JB, Nishi M, Trédaniel J. Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge. Lung Cancer International. 2016. doi:10.1155/2016/6787648
BibTeX
@article{Satg2016,
author = {Satgé, Daniel and Kempf, Emmanuelle and Dubois, Jean-Bernard and Nishi, Motoi and Trédaniel, Jean},
title = {Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge},
journal = {Lung Cancer International},
year = {2016},
doi = {10.1155/2016/6787648}
}
EUVIMED